(Q35073164)

English

Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance). (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

based on heuristic

inferred from title

11

object named as

Kelly K Hunt

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

2

object named as

Vera J Suman

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1

object named as

Judy C Boughey

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Elizabeth A Mittendorf

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Gretchen M Ahrendt

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Lee G Wilke

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Bret Taback

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

A Marilyn Leitch

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Teresa S Flippo-Morton

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Henry M Kuerer

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Monet Bowling

10

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Alliance for Clinical Trials in Oncology

12

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

1 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Annals of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

261

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

547-552

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

8 July 2018

Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

8 July 2018

Factors predicting failure to identify a sentinel lymph node in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

8 July 2018

Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

8 July 2018

Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

8 July 2018

Specification of potential indications and contraindications of sentinel lymph node biopsy in breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

8 July 2018

Sentinel lymph node biopsy, an alternative to elective axillary dissection for breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

8 July 2018

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

27 September 2018

Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

27 September 2018

Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

27 September 2018

Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

27 September 2018

Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

27 September 2018

Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

27 September 2018

Accurate axillary nodal staging can be achieved after neoadjuvant therapy for locally advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

27 September 2018

Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

27 September 2018

Accuracy of axillary sentinel lymph node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of the breast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

27 September 2018

Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

27 September 2018

Does breast tumor location influence success of sentinel lymph node biopsy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

27 September 2018

Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

27 September 2018

Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

27 September 2018

Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

27 September 2018

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy for Advanced Breast Cancer: Results of Ganglion Sentinelle et Chimiothérapie Neoadjuvante, a French Prospective Multicentric Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4324533

16 November 2018

Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25664534

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25664534

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25664534

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25664534

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25664534

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphatic mapping and sentinel lymphadenectomy for breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25664534

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The sentinel node in breast cancer--a multicenter validation study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25664534

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/25664534

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/25664534

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011

1 reference

https://pubmed.ncbi.nlm.nih.gov/25664534

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25664534

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme

1 reference

https://pubmed.ncbi.nlm.nih.gov/25664534

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25664534

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/SLA.0000000000000551

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35073164&oldid=1950136567"